ITU Unit Action

DEXILANT

TAKEDA PHARMACEUTICALS U.S.A., INC.

ITU Unit Action

Trademark Snap Shot ITU Unit Action
(Table presents the data on ITU Unit Action)

OVERVIEW

SERIAL NUMBER 77946349 FILING DATE 02/26/2010
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY GOODMAN, WENDY BETH
L.O. ASSIGNED 109

PUB INFORMATION

RUN DATE 10/15/2010
PUB DATE 07/27/2010
STATUS 748-STATEMENT OF USE - TO EXAMINER
STATUS DATE 10/14/2010
LITERAL MARK ELEMENT DEXILANT

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK NO
LITERAL MARK ELEMENT DEXILANT
MARK DRAWING CODE 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S)
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME Takeda Pharmaceuticals North America, Inc.
ADDRESS One Takeda Parkway
Deerfield, IL 60015
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Pharmaceutical preparations for the treatment of gastrointestinal diseases

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
COLORS CLAIMED STATEMENT Color is not claimed as a feature of the mark.
DESCRIPTION OF MARK The mark consists of the literal element of the mark, "DEXILANT", with an arch design positioned above the "XIL".

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
10/14/2010 SUPC I STATEMENT OF USE PROCESSING COMPLETE 014
09/23/2010 IUAF S USE AMENDMENT FILED 013
10/14/2010 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL 012
09/23/2010 EISU I TEAS STATEMENT OF USE RECEIVED 011
09/21/2010 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT 010
07/27/2010 NPUB E NOTICE OF PUBLICATION E-MAILED 009
07/27/2010 PUBO A PUBLISHED FOR OPPOSITION 008
06/21/2010 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED 007
06/21/2010 ALIE A ASSIGNED TO LIE 006
06/05/2010 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 005
06/02/2010 DOCK D ASSIGNED TO EXAMINER 004
03/04/2010 MDSC O NOTICE OF DESIGN SEARCH CODE MAILED 003
03/03/2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
03/02/2010 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Matthew J. Smith
CORRESPONDENCE ADDRESS MATTHEW J. SMITH
POLSINELLI SHUGHART PC
100 S 4TH ST STE 1100
SAINT LOUIS, MO 63102-1825
DOMESTIC REPRESENTATIVE NONE

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Takeda Pharmaceuticals North America, Inc.
ADDRESS One Takeda Parkway
Deerfield, IL 60015
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

ITU Unit Action [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed